BACKGROUND: Interstitial white matter neurons (IWMNs) may reflect immature neurons that migrate tangentially to the neocortex from the ganglionic eminence to form cortical interneurons. Alterations of interneuron markers have been detected in gray matter of dorsolateral prefrontal cortex in schizophrenia, and IWMNs are also reported to be altered in schizophrenia. In this study, we considered whether a potential link exists between these two pathological findings. METHODS: From a cohort of 29 schizophrenia subjects and 37 control subjects, IWMN densities were determined in the dorsolateral prefrontal cortex by counting neuronal nuclear antigen (NeuN) and somatostatin (SST)-positive cells. Double-label immunofluorescence was carried out to determine the overlap between SST+/NeuN+ and SST+/neuropeptide Y + neurons. RESULTS: We found that density of NeuN + IWMNs in superficial white matter is significantly increased in schizophrenia subjects compared with control subjects. There was a significant negative correlation between SST mRNA expression in gray matter and NeuN + IWMN density. In schizophrenic patients with increased NeuN IWMN density, the density of SST-expressing neurons in white matter was also higher compared with control subjects. A subpopulation of SST immunopositive cells also show coexpression of neuropeptide Y. CONCLUSIONS: Our study confirmed previous results indicating that the density of NeuN + IWMNs is increased in superficial white matter in schizophrenia. We provide the first evidence that increased IWMN density correlates with a gray matter interneuron deficit, suggesting that migration of interneurons from white matter to the cortex may be deficient in some patients with schizophrenia, consistent with an interneuron deficit in schizophrenia.
BACKGROUND: Interstitial white matter neurons (IWMNs) may reflect immature neurons that migrate tangentially to the neocortex from the ganglionic eminence to form cortical interneurons. Alterations of interneuron markers have been detected in gray matter of dorsolateral prefrontal cortex in schizophrenia, and IWMNs are also reported to be altered in schizophrenia. In this study, we considered whether a potential link exists between these two pathological findings. METHODS: From a cohort of 29 schizophrenia subjects and 37 control subjects, IWMN densities were determined in the dorsolateral prefrontal cortex by counting neuronal nuclear antigen (NeuN) and somatostatin (SST)-positive cells. Double-label immunofluorescence was carried out to determine the overlap between SST+/NeuN+ and SST+/neuropeptide Y + neurons. RESULTS: We found that density of NeuN + IWMNs in superficial white matter is significantly increased in schizophrenia subjects compared with control subjects. There was a significant negative correlation between SST mRNA expression in gray matter and NeuN + IWMN density. In schizophrenicpatients with increased NeuN IWMN density, the density of SST-expressing neurons in white matter was also higher compared with control subjects. A subpopulation of SST immunopositive cells also show coexpression of neuropeptide Y. CONCLUSIONS: Our study confirmed previous results indicating that the density of NeuN + IWMNs is increased in superficial white matter in schizophrenia. We provide the first evidence that increased IWMN density correlates with a gray matter interneuron deficit, suggesting that migration of interneurons from white matter to the cortex may be deficient in some patients with schizophrenia, consistent with an interneuron deficit in schizophrenia.
Authors: Daniel W Meechan; Eric S Tucker; Thomas M Maynard; Anthony-Samuel LaMantia Journal: Proc Natl Acad Sci U S A Date: 2009-09-10 Impact factor: 11.205
Authors: T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis Journal: Mol Psychiatry Date: 2007-05-01 Impact factor: 15.992
Authors: Kazue Hashimoto-Torii; Masaaki Torii; Matthew R Sarkisian; Christopher M Bartley; Jie Shen; Freddy Radtke; Thomas Gridley; Nenad Sestan; Pasko Rakic Journal: Neuron Date: 2008-10-23 Impact factor: 17.173
Authors: Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis Journal: Am J Psychiatry Date: 2008-02-15 Impact factor: 18.112
Authors: Yan Cai; Kun Xiong; Yaping Chu; Duan-Wu Luo; Xue-Gang Luo; Xian-Yui Yuan; Robert G Struble; Richard W Clough; Dennis D Spencer; Anne Williamson; Jeffrey H Kordower; Peter R Patrylo; Xiao-Xin Yan Journal: Exp Neurol Date: 2008-12-25 Impact factor: 5.330
Authors: Stefano Marenco; Jason L Stein; Antonina A Savostyanova; Fabio Sambataro; Hao-Yang Tan; Aaron L Goldman; Beth A Verchinski; Alan S Barnett; Dwight Dickinson; José A Apud; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853
Authors: Arash Nazeri; M Mallar Chakravarty; Daniel Felsky; Nancy J Lobaugh; Tarek K Rajji; Benoit H Mulsant; Aristotle N Voineskos Journal: Neuropsychopharmacology Date: 2013-04-16 Impact factor: 7.853
Authors: Tobias B Halene; Alexey Kozlenkov; Yan Jiang; Amanda C Mitchell; Behnam Javidfar; Aslihan Dincer; Royce Park; Jennifer Wiseman; Paula L Croxson; Eustathia Lela Giannaris; Patrick R Hof; Panos Roussos; Stella Dracheva; Scott E Hemby; Schahram Akbarian Journal: Schizophr Res Date: 2016-01-06 Impact factor: 4.939